Evidence check: FTO in the context of blood sugar

The FTO gene (fat mass and obesity-associated) is strongly linked to obesity via GWAS. Regarding blood sugar, human studies show associations between FTO variants (e.g., rs9939609) and increased risk of type 2 diabetes as well as elevated fasting glucose. However, this effect is largely mediated by BMI – after adjusting for adiposity, the association often weakens or becomes non-significant. Some mechanistic work suggests a direct role of FTO in insulin sensitivity and glucose homeostasis, but evidence is inconsistent. Consumer DNA tests often market FTO as a 'blood sugar gene,' oversimplifying the complex reality. The clinical relevance for an individual is limited; lifestyle factors (diet, exercise) have a far greater impact on blood glucose. Conclusion: Evidence for a direct, independent effect of FTO on blood sugar is moderate and confounded by obesity. Overinterpreting this single SNP is not advisable.